Tag: biotechnology

July 23, 2024
The most recent and prominent United States (US) attempt to limit cooperation with Chinese life science businesses has stalled, but is hardly dead.  Current Speaker of the House Mike Johnson said he intends to have the BIOSECURE Act signed into law before the end of 2024.[1]  Irrespective of the impasse,...
March 25, 2024
In January 2024, Congressman Mike Gallagher, the Chair of the United States (US) House Committee on the Chinese Communist Party, introduced the “Biosecure Act,” which prohibits the US government (USG) from “procuring or obtaining biotechnology equipment or services produced or provided by a biotechnology company of concern,” participating in a...
June 13, 2023
The United States (US) has been striving for some time to hinder China’s acquisition of technology-related hardware, software, and intellectual property (IP) through export controls, limits on Chinese investment in American high-tech firms, and even investigations of researchers tied to Chinese universities and think tanks.  The goal ostensibly is to...
August 4, 2021
Possessing about a decade-long lineage, China’s Greater Bay Area (GBA) formally began in 2017 with the signing of a Framework Agreement between the People’s Republic of China (PRC) and the Hong Kong Special Administrative Region.  The objective is to create a mega economic cluster, involving 11 cities (e.g., Guangzhou, Dongguan,...
August 5, 2019
China has opened the upstream exploration of its oil and natural gas resources by foreign investors by scrapping joint venture (JV) restrictions. In the first half of the year, the top geographic destination for Chinese inward foreign direct investment (FDI) continued to be Jiangsu, which attracted large amounts of inward…
June 1, 2019
Foreign direct investment (FDI) and domestic firms, lured by, respectively, China’s consumer stimulus and attractive valuations may mitigate the adverse effects of the US-China trade war on China. The trade war and new regulatory environment is driving Fosun to limit its investments in United States (US) biotech companies and to…